BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2557005)

  • 1. Differential sensitivity of anti-IgM-induced and NaF-induced inositol phospholipid metabolism to serine protease inhibitors in BAL17 B lymphoma cells.
    Mizuguchi J; Utsunomiya N; Nakanishi M; Arata Y; Fukazawa H
    Biochem J; 1989 Nov; 263(3):641-6. PubMed ID: 2557005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase C activation blocks anti-IgM-mediated signaling BAL17 B lymphoma cells.
    Mizuguchi J; Ji YY; Nakabayaschi H; Huang KP; Beaven MA; Chused T; Paul WE
    J Immunol; 1987 Aug; 139(4):1054-9. PubMed ID: 3038996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane IgM, IgD, and IgG act as signal transmission molecules in a series of B lymphomas.
    Mizuguchi J; Tsang W; Morrison SL; Beaven MA; Paul WE
    J Immunol; 1986 Oct; 137(7):2162-7. PubMed ID: 3020122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine protein kinase is involved in anti-IgM-mediated signaling in BAL17 B lymphoma cells.
    Mizuguchi J; Yamanashi Y; Ehara K; Tamura T; Nariuchi H; Gyotoku Y; Fukazawa H; Uehara Y; Yamamoto T
    J Immunol; 1992 Feb; 148(3):689-94. PubMed ID: 1730866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered signal transduction secondary to surface IgM cross-linking on B-chronic lymphocytic leukemia cells. Differential activation of the phosphatidylinositol-specific phospholipase C.
    Hivroz C; Gény B; Brouet JC; Grillot-Courvalin C
    J Immunol; 1990 Mar; 144(6):2351-8. PubMed ID: 2107258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-linking membrane IgM induces production of inositol trisphosphate and inositol tetrakisphosphate in WEHI-231 B lymphoma cells.
    Fahey KA; DeFranco AL
    J Immunol; 1987 Jun; 138(11):3935-42. PubMed ID: 3035017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phorbol myristate acetate inhibits increases in membrane fluidity induced by anti-IgM in B cells.
    Mizuguchi J; Utsunomiya N; Nakanishi M; Arata Y
    J Immunol; 1988 Apr; 140(8):2495-9. PubMed ID: 3258610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of tryptase and histamine release from human lung mast cells by protease inhibitors.
    He S; Xie H
    Asian Pac J Allergy Immunol; 2004 Dec; 22(4):205-12. PubMed ID: 15783133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling through surface IgM in tolerance-susceptible immature murine B lymphocytes. Developmentally regulated differences in transmembrane signaling in splenic B cells from adult and neonatal mice.
    Yellen AJ; Glenn W; Sukhatme VP; Cao XM; Monroe JG
    J Immunol; 1991 Mar; 146(5):1446-54. PubMed ID: 1847161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of surface IgM- and IgD-mediated inositol phosphate formation and Ca2+ mobilization in murine B lymphocytes.
    Harnett MM; Holman MJ; Klaus GG
    Eur J Immunol; 1989 Oct; 19(10):1933-9. PubMed ID: 2555196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex.
    Carter RH; Tuveson DA; Park DJ; Rhee SG; Fearon DT
    J Immunol; 1991 Dec; 147(11):3663-71. PubMed ID: 1719083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential suppression by protease inhibitors and cytokines of apoptosis induced by wild-type p53 and cytotoxic agents.
    Lotem J; Sachs L
    Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12507-12. PubMed ID: 8901612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane IgM cross-linking is not coupled to protein kinase C translocation in WEHI-231 B lymphoma cells.
    Sarthou P; Henry-Toulmé N; Cazenave PA
    Eur J Immunol; 1989 Jul; 19(7):1247-52. PubMed ID: 2668012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-linking of membrane IgM on B CLL cells: dissociation between intracellular free Ca2+ mobilization and cell proliferation.
    Hivroz C; Grillot-Courvalin C; Labaume S; Miglierina R; Brouet JC
    Eur J Immunol; 1988 Nov; 18(11):1811-7. PubMed ID: 3144454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of a guanine-nucleotide-binding component in membrane IgM-stimulated phosphoinositide breakdown.
    Gold MR; Jakway JP; DeFranco AL
    J Immunol; 1987 Dec; 139(11):3604-13. PubMed ID: 2824610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serine protease inhibitors N-alpha-tosyl-L-lysinyl-chloromethylketone (TLCK) and N-tosyl-L-phenylalaninyl-chloromethylketone (TPCK) are potent inhibitors of activated caspase proteases.
    Frydrych I; Mlejnek P
    J Cell Biochem; 2008 Apr; 103(5):1646-56. PubMed ID: 17879947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane IgM and IgD molecules fail to transduce Ca2+ mobilizing signals when expressed on differentiated B lineage cells.
    Justement LB; Wienands J; Hombach J; Reth M; Cambier JC
    J Immunol; 1990 May; 144(9):3272-80. PubMed ID: 2109774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids suppress calcium mobilization and phospholipid hydrolysis in anti-Ig antibody-stimulated B cells.
    Dennis G; June CH; Mizuguchi J; Ohara J; Witherspoon K; Finkelman FD; McMillan V; Mond JJ
    J Immunol; 1987 Oct; 139(8):2516-23. PubMed ID: 2821117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of phosphoinositide-derived second messengers in mediating anti-IgM-induced growth arrest of WEHI-231 B lymphoma cells.
    Page DM; DeFranco AL
    J Immunol; 1988 Jun; 140(11):3717-26. PubMed ID: 2836499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can application of serine protease inhibitors TPCK and TLCK provide evidence for possible involvement of serine protease Omi/HtrA2 in imatinib mesylate-induced cell death of BCR-ABL-positive human leukemia cells?
    Mlejnek P
    Leukemia; 2005 Jun; 19(6):1085-7. PubMed ID: 15800674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.